This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Asset 3
  • About
  • People
  • Capabilities
  • Insights
  • Careers
  • Public Interest
  • Inclusion
  • Contact us
    Contact us
  • Locations
    Locations
  • Search
    Search
  • About
    • About
    • Message From the CEO
    • Firm History
    • Alumni
    • Alumni
    • In Memoriam
  • People
  • Capabilities
    • Practices
    • Industries
    • Global Reach: The Law Firm Network
    • Bankruptcy & Restructuring
    • Brand & Reputation Management
    • Intellectual Property
    • Litigation & Dispute Resolution
    • Special Situations, Distressed Debt and Debt Trading
    • Transactions
    • Tax
    • White Collar Defense, Investigations & Compliance
    • Energy & Environmental
    • Entertainment & Media
    • Investment Management 
    • Life Sciences
    • Technology
    • Real Estate
    • Bankruptcy & Restructuring
    • Bankruptcy Litigation
    • Mass Torts Bankruptcy
    • Intellectual Property
    • Intellectual Property Litigation
    • Patents
    • Trademark, Copyright & Advertising
    • Patent Trial and Appeals Board (PTAB)
    • Litigation & Dispute Resolution
    • Civil Fraud Litigation
    • Employment Practices and Litigation
    • Government Contracts Litigation
    • Intellectual Property Litigation
    • Insurance Recovery
    • Litigation Funding
    • M&A and Private Equity Litigation
    • Real Estate Litigation
    • Patent Trial and Appeals Board (PTAB)
    • UK Tax Controversy & Litigation
    • Special Situations, Distressed Debt and Debt Trading
    • Distressed Debt & Claims Trading
    • Litigation Funding
    • Finance
    • Real Estate Special Situations
    • Transactions
    • Capital Markets
    • Cross-Border Transactions
    • Emerging Growth Companies & Venture Capital
    • Employment
    • Finance
    • Franchising
    • Mergers & Acquisitions
    • Tax
    • White Collar Defense, Investigations & Compliance
    • Economic Sanctions & Export Controls
    • Energy & Environmental
    • Energy
    • Energy Transition
    • Environmental
    • Entertainment & Media
    • Brand & Reputation Management
    • Intellectual Property
    • Sports
    • Investment Management
    • Fund Formation
    • Private Equity Transactions
    • Distressed Debt
    • Emerging Growth Companies & Venture Capital
    • Family-Owned & Closely Held Businesses
    • Private Equity Litigation
    • Life Sciences
    • BR BioAdvisory Services
    • Technology
    • Artificial Intelligence
    • Cybersecurity & Data Privacy
    • Digital Commerce
    • Fintech
    • Real Estate
    • Hospitality & Leisure
    • Distressed Real Estate
    • Real Estate Special Situations
    • Real Estate Litigation
    • Wireless Network Infrastructure
  • Insights
    • Client News
    • Firm News
    • Briefings
    • Events
    • Podcasts
  • Careers
    • Experienced Lawyers
    • U.S. Law Students
    • London Trainee Program
    • Business Professionals
    • Professional Development
  • Public Interest
    • Brown Rudnick Charitable Foundation
    • Pro Bono & Community Service
  • Inclusion
    • Inclusion
    • Women in Business Series
  • Contact Us
  • Location
  • Search
  • About
    • About
    • Message From the CEO
    • Firm History
    • Alumni
    • Alumni
    • In Memoriam
  • People
  • Capabilities
    • Practices
    • Industries
    • Global Reach: The Law Firm Network
    • Bankruptcy & Restructuring
    • Brand & Reputation Management
    • Intellectual Property
    • Litigation & Dispute Resolution
    • Special Situations, Distressed Debt and Debt Trading
    • Transactions
    • Tax
    • White Collar Defense, Investigations & Compliance
    • Energy & Environmental
    • Entertainment & Media
    • Investment Management 
    • Life Sciences
    • Technology
    • Real Estate
    • Bankruptcy & Restructuring
    • Bankruptcy Litigation
    • Mass Torts Bankruptcy
    • Intellectual Property
    • Intellectual Property Litigation
    • Patents
    • Trademark, Copyright & Advertising
    • Patent Trial and Appeals Board (PTAB)
    • Litigation & Dispute Resolution
    • Civil Fraud Litigation
    • Employment Practices and Litigation
    • Government Contracts Litigation
    • Intellectual Property Litigation
    • Insurance Recovery
    • Litigation Funding
    • M&A and Private Equity Litigation
    • Real Estate Litigation
    • Patent Trial and Appeals Board (PTAB)
    • UK Tax Controversy & Litigation
    • Special Situations, Distressed Debt and Debt Trading
    • Distressed Debt & Claims Trading
    • Litigation Funding
    • Finance
    • Real Estate Special Situations
    • Transactions
    • Capital Markets
    • Cross-Border Transactions
    • Emerging Growth Companies & Venture Capital
    • Employment
    • Finance
    • Franchising
    • Mergers & Acquisitions
    • Tax
    • White Collar Defense, Investigations & Compliance
    • Economic Sanctions & Export Controls
    • Energy & Environmental
    • Energy
    • Energy Transition
    • Environmental
    • Entertainment & Media
    • Brand & Reputation Management
    • Intellectual Property
    • Sports
    • Investment Management
    • Fund Formation
    • Private Equity Transactions
    • Distressed Debt
    • Emerging Growth Companies & Venture Capital
    • Family-Owned & Closely Held Businesses
    • Private Equity Litigation
    • Life Sciences
    • BR BioAdvisory Services
    • Technology
    • Artificial Intelligence
    • Cybersecurity & Data Privacy
    • Digital Commerce
    • Fintech
    • Real Estate
    • Hospitality & Leisure
    • Distressed Real Estate
    • Real Estate Special Situations
    • Real Estate Litigation
    • Wireless Network Infrastructure
  • Insights
    • Client News
    • Firm News
    • Briefings
    • Events
    • Podcasts
  • Careers
    • Experienced Lawyers
    • U.S. Law Students
    • London Trainee Program
    • Business Professionals
    • Professional Development
  • Public Interest
    • Brown Rudnick Charitable Foundation
    • Pro Bono & Community Service
  • Inclusion
    • Inclusion
    • Women in Business Series

Search People

Search by last name

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

see all people
Asset 3
  • LinkedIn
  • X (formerly known as Twitter)
  • Facebook
  • Instagram
  • Threads
  • YouTube
  • rss
  • Contact Us
  • Terms of Use
  • Privacy
  • Sitemap
  • LinkedIn
  • X (formerly known as Twitter)
  • Facebook
  • Instagram
  • Threads
  • YouTube
  • rss

© 2024 Brown Rudnick LLP. Attorney advertising.

All Rights Reserved.

Team Archive Subscribe
    • All (531)
    • 2025 (14)
    • 2024 (91)
    • 2023 (96)
    • 2022 (88)
    • 2021 (81)
    • 2020 (108)
    • 2019 (45)
    • 2018 (5)
    • 2017 (3)
    • Apr (2)
    • Oct (1)
    • Jan (1)
    • Feb (1)
    • Apr (1)
    • Jun (1)
    • Dec (1)
    • Jan (3)
    • Feb (6)
    • Mar (3)
    • Apr (6)
    • May (5)
    • Jun (4)
    • Jul (2)
    • Aug (1)
    • Sep (4)
    • Oct (5)
    • Nov (4)
    • Dec (2)
    • Jan (3)
    • Feb (1)
    • Mar (20)
    • Apr (23)
    • May (10)
    • Jun (9)
    • Jul (10)
    • Aug (4)
    • Sep (8)
    • Oct (9)
    • Nov (4)
    • Dec (7)
    • Jan (5)
    • Feb (6)
    • Mar (11)
    • Apr (10)
    • May (14)
    • Jun (5)
    • Jul (6)
    • Aug (2)
    • Sep (3)
    • Oct (5)
    • Nov (9)
    • Dec (5)
    • Jan (4)
    • Feb (7)
    • Mar (6)
    • Apr (7)
    • May (22)
    • Jun (10)
    • Jul (7)
    • Aug (5)
    • Sep (2)
    • Oct (6)
    • Nov (7)
    • Dec (5)
    • Jan (9)
    • Feb (7)
    • Mar (13)
    • Apr (8)
    • May (4)
    • Jun (4)
    • Jul (10)
    • Aug (2)
    • Sep (7)
    • Oct (12)
    • Nov (7)
    • Dec (13)
    • Jan (10)
    • Feb (13)
    • Mar (16)
    • Apr (9)
    • May (8)
    • Jun (5)
    • Jul (8)
    • Aug (2)
    • Sep (4)
    • Nov (3)
    • Dec (13)
    • Jan (2)
    • Feb (4)
    • Mar (7)
    • Apr (1)
    3 results for: fda
    AI Biotech CEO Admits to Raising $40M Without Disclosing Clinical Holds
    12/5/2024 9:13:37 PM

    AI Biotech CEO Admits to Raising $40M Without Disclosing Clinical Holds
    By Daniel Sachs
    Kiromic BioPharma Inc. (the Company), its former CEO, Maurizio Chiriva-Internati and former CFO Tony Tontat admitted to raising $40...
    42
    213
    255
    In Thomson Reuters: Best Practices on Protecting Trade Secrets
    4/12/2022 5:04:00 PM

    In Thomson Reuters: Best Practices on Protecting Trade Secrets
    By Ian DiBernardo Jason Sobel Marcus Strong
    In an article for Thomson Reuters’ Westlaw Today, Partners Ian DiBernardo and Jason Sobel and Associate Marcus Strong examine a recent...
    Life Sciences Spotlight: BR Team Examines FDA Guidance on Gene Therapies
    3/16/2022 9:46:00 AM

    Life Sciences Spotlight: BR Team Examines FDA Guidance on Gene Therapies
    By Adam Schoen Robert B. Ruh III
    Adam Schoen and Robert Ruh co-authored an article examining the FDA’s guidance on clinical recommendations for “N of 1” gene therapies....